Lyndon Gommersall

Queen Elizabeth Hospital Birmingham

Papers

1

Total Citations

9

H-Index

1

About

Dr. Lyndon Gommersall is a distinguished urological surgeon and researcher whose work centers on advancing the surgical management of prostate cancer, with a particular focus on refining treatment outcomes and surgical techniques. His major contributions include pioneering the use of ultrasensitive prostate specific antigen (PSA) assays to objectively define the learning curve for laparoscopic radical prostatectomy, a critical advancement that helps surgeons and institutions benchmark proficiency and improve patient care. His landmark 2009 study, which has garnered 9 citations, demonstrated how postoperative PSA kinetics can serve as a precise outcome measure, directly impacting surgical training and quality assurance in minimally invasive prostate cancer surgery. Beyond this, Dr. Gommersall’s research has influenced protocols for monitoring biochemical recurrence and optimizing surgical recovery. His work bridges the gap between technical surgical skill and measurable patient outcomes, making him a key figure in evidence-based urological oncology. For students and researchers, his studies underscore the importance of integrating novel biomarkers with surgical innovation to enhance precision in cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Ultrasensitive Prostate Specific Antigen Assay Following Laparoscopic Radical Prostatectomy – An Outcome Measure for Defining the Learning Curve
9 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Queen Elizabeth Hospital Birmingham

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago